{
    "Trade/Device Name(s)": [
        "Indiko Clinical Chemistry Analyzer",
        "Indiko Glucose (HK)"
    ],
    "Submitter Information": "Thermo Fisher Scientific Oy",
    "510(k) Number": "K110035",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061107"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFR",
        "JJE"
    ],
    "Summary Letter Date": "June 15, 2011",
    "Summary Letter Received Date": "June 15, 2011",
    "Submission Date": "June 9, 2011",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.2160"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Discrete photometric chemistry analyzer for clinical chemistry"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Indiko Clinical Chemistry Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric assay",
        "Hexokinase enzymatic method"
    ],
    "Methodologies": [
        "Discrete photometric analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Thermo Scientific Indiko Clinical Chemistry Analyzer and Indiko Glucose (HK) photometric assay for quantitative glucose determination in plasma.",
    "Indications for Use Summary": "For in vitro diagnostic quantitative determination of glucose concentration in human plasma using the Indiko analyzer to aid in diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and hypoglycemia.",
    "fda_folder": "Clinical Chemistry"
}